This inventor holds 31 USPTO granted patents, primarily in Auto-Injector Technology. Top assignees: Ucb Biopharma Sprl, Ucb Pharma, S.a., Bespak Europe Limited. Active years: 2012-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hemel Hempstead, GB (2012 - 2017)
- Berkshire, GB (2017 - 2019)
- Oakington, GB (2019)
- Burnham, GB (2015 - 2020)
- Slough, GB (2021 - 2022)
Company Filing History:
23 out of 139 
7 out of 180 
3 out of 5 Years Active: 2012-2022
Areas of Expertise:
Title: Martin John McLoughlin: Innovator in Auto-Injector Technologies
Introduction
Martin John McLoughlin is a notable inventor based in Burnham, GB, with an impressive portfolio comprising 31 patents. His contributions predominantly focus on advancements in auto-injector devices, showcasing his commitment to enhancing medical technologies.
Latest Patents
Among his latest patents, McLoughlin has developed an "Assembly for an auto-injector device." This innovative assembly includes a syringe support designed to limit the forward axial movement of the syringe while providing an attachment for a guard element. The guard element is anchored securely to the syringe support, allowing it to withstand forwardly directed axial loads. Another key invention is his "Housing part for an auto-injector," featuring a shell body that combines a hard material with a softer over-coating. This design not only protects the inner components but also enhances user interaction through its ergonomic features.
Career Highlights
Throughout his career, McLoughlin has worked with prominent companies in the pharmaceutical sector, including UCB Biopharma Sprl and UCB Pharma, S.A. His engineering expertise has led to significant advancements in auto-injector technologies, making him a valuable asset in the industry.
Collaborations
In his professional journey, McLoughlin has collaborated with esteemed colleagues such as Michael James David Heald and Kevin Richard Lozeau. Their collaboration has likely played a vital role in driving innovation and expanding the horizons of medical device technologies.
Conclusion
Martin John McLoughlin continues to be a pioneering inventor in the field of auto-injectors, contributing valuable advancements that enhance patient care and treatment efficiency. His dedication to innovation and collaboration underscores the importance of teamwork in driving the next generation of medical technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile